Company Quick10K Filing
Cooper Companies
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 50 $15,093
10-K 2019-12-20 Annual: 2019-10-31
10-Q 2019-08-30 Quarter: 2019-07-31
10-Q 2019-05-31 Quarter: 2019-04-30
10-Q 2019-03-06 Quarter: 2019-01-31
10-K 2018-12-21 Annual: 2018-10-31
10-Q 2018-08-31 Quarter: 2018-07-31
10-Q 2018-06-08 Quarter: 2018-04-30
10-Q 2018-03-09 Quarter: 2018-01-31
10-K 2017-12-22 Annual: 2017-10-31
10-Q 2017-09-01 Quarter: 2017-07-31
10-Q 2017-06-02 Quarter: 2017-04-30
10-Q 2017-03-03 Quarter: 2017-01-31
10-K 2016-12-22 Annual: 2016-10-31
10-Q 2016-09-02 Quarter: 2016-07-31
10-Q 2016-06-03 Quarter: 2016-04-30
10-Q 2016-03-04 Quarter: 2016-01-31
10-K 2015-12-18 Annual: 2015-10-31
10-Q 2015-09-04 Quarter: 2015-07-31
10-Q 2015-06-05 Quarter: 2015-04-30
10-Q 2015-03-06 Quarter: 2015-01-31
10-K 2014-12-19 Annual: 2014-10-31
10-Q 2014-09-05 Quarter: 2014-07-31
10-Q 2014-06-06 Quarter: 2014-04-30
10-Q 2014-03-07 Quarter: 2014-01-31
10-K 2013-12-20 Annual: 2013-10-31
10-Q 2013-09-06 Quarter: 2013-07-31
10-Q 2013-06-07 Quarter: 2013-04-30
10-Q 2013-03-08 Quarter: 2013-01-31
10-K 2012-12-20 Annual: 2012-10-31
10-Q 2012-09-07 Quarter: 2012-07-31
10-Q 2012-06-08 Quarter: 2012-04-30
10-Q 2012-03-09 Quarter: 2012-01-31
10-K 2011-12-16 Annual: 2011-10-31
10-Q 2011-09-02 Quarter: 2011-07-31
10-Q 2011-06-03 Quarter: 2011-04-30
10-Q 2011-03-04 Quarter: 2011-01-31
10-K 2010-12-17 Annual: 2010-10-31
10-Q 2010-09-03 Quarter: 2010-07-31
10-Q 2010-06-04 Quarter: 2010-04-30
10-Q 2010-03-05 Quarter: 2010-01-31
8-K 2019-12-10 Officers, Exhibits
8-K 2019-12-05 Earnings, Exhibits
8-K 2019-09-27 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2019-08-29 Earnings, Exhibits
8-K 2019-05-30 Earnings, Exhibits
8-K 2019-04-17 Officers
8-K 2019-03-18 Shareholder Vote
8-K 2019-03-05 Earnings, Exhibits
8-K 2018-12-12 Enter Agreement, Amend Bylaw, Exhibits
8-K 2018-12-06 Earnings, Exhibits
8-K 2018-11-01 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-08-30 Earnings, Exhibits
8-K 2018-06-07 Earnings, Exhibits
8-K 2018-05-01 Officers
8-K 2018-04-23 Officers, Exhibits
8-K 2018-04-10 Officers
8-K 2018-03-19 Shareholder Vote
8-K 2018-03-08 Earnings, Exhibits
8-K 2018-03-08 Officers, Regulation FD, Exhibits
8-K 2018-01-04 Other Events

Cooper Companies Financials

COO Metrics, Comps, Filings

Annual | Quarterly

Business

The Cooper Companies, Inc. (Cooper, we or the Company), a Delaware corporation organized in 1980, is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical.

CooperVision is a global manufacturer providing products for contact lens wearers. CooperVision develops, manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues; with a broad collection of spherical, toric and multifocal contact lenses. Acquisitions also expanded CooperVision's access to myopia management and specialty eye care markets with new products, such as orthokeratology (ortho-k) and scleral lenses. In November 2019, CooperVision received United States Food & Drug Administration (FDA) approval for its MiSight® 1day lens, which is the first and only FDA-approved product indicated to slow the progression of myopia in children with treatment initiated between the ages of 8-12 and is expected to be available in the United States in 2020. Further, CooperVision offers contact lenses in a variety of materials including silicone hydrogel Aquaform® technology and phosphorylcholine technology (PC) Technology™. CooperVision's major manufacturing and distribution facilities are located in the United Kingdom, Puerto Rico, Hungary, Costa Rica, Belgium and the United States, with other smaller locations also existing in multiple locations around the world.

CooperSurgical's business competes in the general health care market with a focus on advancing the health of women, babies and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. CooperSurgical has established its market presence and distribution system by developing products and acquiring companies, products and services that complement its business model. We categorize CooperSurgical product sales based on the point of health care delivery, which includes products used in medical office and surgical procedures, primarily by Obstetricians/Gynecologists (OB/GYN); and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories. CooperSurgical's major manufacturing and distribution facilities are located in the United States, Costa Rica, the Netherlands, and the United Kingdom with other smaller locations also existing in multiple locations around the world.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
AmerisourceBergen (ABC) 18,082 3% 13.0 2% 38,479 35,489 177,248 4,986 957 1,485 19,267
Histogenics (HSGX) 17,974 -6,695.7 -84% 3 12 0 -1 -3 -3 17,971
ResMed (RMD) 17,425 59% 21.9 10% 4,108 2,035 2,607 1,537 405 848 18,540
Laboratory of America (LH) 16,943 28% 9.7 5% 17,744 10,580 11,292 3,177 854 2,348 22,813
Biomarin Pharmaceutical (BMRN) 15,774 79% 680.7 -3% 4,393 1,432 1,533 1,213 -110 24 16,336
Teleflex (TFX) 15,750 57% 29.3 4% 6,314 3,650 2,521 1,426 271 600 17,595
Cooper Companies (COO) 15,093 66% 20.0 7% 6,173 2,557 2,613 1,732 446 818 16,402
Exact Sciences (EXAS) 14,884 74% -79.0 -12% 1,782 1,016 623 460 -221 -186 14,679
WellCare Health Plans (WCG) 14,540 77% 12.1 4% 13,206 8,602 24,901 19,250 521 1,110 13,453
Quest Diagnostics (DGX) 13,740 34% 11.7 7% 11,760 6,301 7,572 2,606 781 1,489 17,443
Cardinal Health (CAH) 13,735 5% 6.2 3% 40,963 34,635 145,534 6,835 1,365 3,046 18,783
Hologic (HOLX) 13,139 40% 32.5 -0% 6,522 4,306 3,315 1,342 -30 485 15,764
Dentsply Sirona (XRAY) 13,003 52% 29.7 1% 8,575 3,392 3,944 2,041 105 478 14,194
Dexcom (DXCM) 12,908 63% -140.0 -8% 2,066 1,378 1,222 767 -170 -87 12,198
Varian Medical Systems (VAR) 12,531 42% 22.5 9% 3,967 2,210 3,148 1,324 338 533 11,989
Elanco Animal Health (ELAN) 12,085 52% 30.6 2% 8,857 3,591 3,073 1,591 144 460 14,098
ABIOMED (ABMD) 11,806 83% 35.8 23% 1,125 122 797 661 258 327 11,705
National Vision (EYE) 2,563 55% 39.9 1% 2,072 1,297 1,708 937 15 77 3,058
Staar Surgical (STAA) 1,414 75% 98.6 4% 186 42 135 101 8 13 1,311

Balance Sheet ($MM)2010-10-312011-10-312012-10-312013-10-312014-10-312015-10-312016-10-312017-10-312018-10-31
Cash45137725161018980
Accounts Receivable197215234230276283291317375
Inventory228254320339381420418454469
PP&E5946096401,241937967878910976
Assets2,5252,6252,9413,1374,4584,4614,4764,8596,113
Accounts Payable526285108116117107142146
Long-Term Debt5923403483021,2811,1101,3181,1491,986
Liabilities8586877287141,8701,7871,7761,6832,805
Stockholders' Equity1,6671,9372,1932,4052,5702,6682,7003,1763,308
Income Statement ($MM)2010-10-312011-10-312012-10-312013-10-312014-10-312015-10-312016-10-312017-10-312018-10-31
Revenue1,1591,3311,4451,5881,7181,7971,9672,1392,533
Cost of Revenue482526521561626727794773900
Gross Profit6778059241,0271,0921,0701,1731,3661,632
R&D354452596670656985
SG&A433513565611683713723799973
Tax1217271516122916192
Net Income113175249297272205275373140
Cash Flow ($MM)2010-10-312011-10-312012-10-312013-10-312014-10-312015-10-312016-10-312017-10-312018-10-31
Cash Operating268336315416455391510594669
Cash Investing-107-162-238-190-1,346-288-419-381-1,518
Cash Financing-162-173-68-162842-107-1-228844